Westmead Health Precinct

Name

Westmead Health Precinct

Legal name

Westmead Health Precinct

Website

https://westmeadhealthprecinct.com

Company type

Private

Founded year

2020

Operating status

Operating

Ownership category

akta.pro rank

Product category

Public Healthcare and Medical Research Precinct

NAICS

General Medical and Surgical Hospitals (622110), General Medical and Surgical Hospitals (6221), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215), Health Care and Social Assistance (62)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Medical Laboratories (8071), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Global Health Institutes & Programs (EDAHAGAM), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Health research precinct
• Medical research services
• Clinical trial operations
• Translational medicine
• Public healthcare delivery

Headquarters

HQ city

Westmead

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Public Healthcare Services: Government-funded public healthcare services provided through Western Sydney Local Health District and Sydney Children's Hospitals Network to more than 946,000 residents in Sydney's west.
2. Research Funding and Grants: Medical research conducted across multiple research entities funded through government grants, philanthropic donations, and commercial partnerships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

The Westmead Health Precinct is a collaborative health, innovation, research, education and training hub that coordinates public hospital services, medical research, clinical trials, and health professional education across 4 hospitals, 5 medical research entities, and 2 university campuses. It delivers advanced therapeutics (gene therapy, phage therapy, viral vectors, CAR T-cell therapy), translational cancer research, infectious diseases research, digital health analytics, and viral vector manufacturing services to bio-pharma and research clients. Its services are accessed by more than 946,000 residents of Western Sydney and by researchers, clinicians, students, and industry partners.

Product overview

The Westmead Health Precinct is one of Australia's largest health, innovation, research, education and training hubs—not a single unified software product, but rather a collaborative ecosystem. It comprises 4 major hospitals (WSLHD, The Children's Hospital at Westmead), 5 medical research entities (CMRI, WIMR, NSW Health Pathology, NCIRS), 2 university campuses (University of Sydney), and multiple specialized programs including Advanced Therapeutics (viral vectors, phage therapy, CAR T-cell), Translational Cancer Research (ProCan, particle therapy), Clinical Trials (nearly 3000 active), and Digital Health & Big Data initiatives. Key infrastructure includes the Viral Vector Manufacturing Facility (VVMF), Cicada Innovations HealthTech Hub, and the upcoming Health Enterprise Zone. The precinct also hosts community programs like the Safer Cities initiative and innovation events including the Harvard Hackathon and Innovate Western Sydney. WSLHD employs over 13,000 people across the precinct, which conducts over 2000 research projects annually with access to over $28M in shared research equipment.

Differentiator

Problem solved

Functional benefit

Brands

• WE: A concept representing Westmead, Western Sydney, collaboration, and shared purpose within the precinct.

Products and services

• Viral Vector Manufacturing Facility (VVMF) An Australian Contract Development Manufacturing Organisation (CDMO) providing services in research, design, development, and manufacture of lentiviral and adeno-associated viral vectors for advanced therapeutic applications including cell and gene therapies. Partners with researchers, clinicians, and bio-pharma companies to accelerate cell and gene therapies to patients.
• Clinical Trials Services More clinical trials than any location in NSW, with nearly 3,000 active clinical trials and studies at any one time covering spinal muscular atrophy, Duchenne muscular dystrophy, COVID-19, phage therapy, ovarian cancer, and hepatology research. Provides sponsors and researchers with access to diverse patient populations and clinical research infrastructure.
• Cicada Innovations HealthTech Hub at Westmead Powered by NSW Government, the HealthTech Hub is home to early stage health companies, providing space for collaboration and commercialisation activation, and serving as a landing pad for industry seeking solutions to research and business challenges. Provides incubation services for health tech startups and entrepreneurs.

Quantifiable outcome

• Leading the globe in gene therapy, phage therapy, and viral vector technologies
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

21 partnerships are on record, tiered supporting, core and minor.

• Transport for NSW - Safer Cities ProgramsupportingStrategic or Co-development Partner · 1 January 2023Collaborative partnership between Westmead Health Precinct and Safer Cities program, a state-wide program funded by Transport for NSW, to increase perception of safety for women, girls and gender diverse people.
• Western Sydney Local Health District (WSLHD)coreStrategic or Co-development PartnerWSLHD is a leader in clinical services, research, and education providing diverse range of public healthcare to more than 946,000 residents in Sydney's west. Employs more than 13,000 dedicated people across five hospitals with around 8,000 based at Westmead. Core partner in the precinct governance and operations.
• Sydney Children's Hospitals Network (SCHN)coreStrategic or Co-development PartnerSCHN is Australia's largest provider of health services for children and young people, comprising The Children's Hospital at Westmead, Sydney Children's Hospital Randwick, Kids Research, NETS, Bear Cottage and Children's Court Clinic. The Children's Hospital at Westmead has a proud legacy of embedding research into paediatric care.
• Children's Medical Research Institute (CMRI)coreStrategic or Co-development PartnerCMRI performs cutting-edge research to find effective treatments for serious childhood illnesses, especially those with a genetic basis – cancer and inherited diseases. CMRI's scientists address key areas of unmet need in children's health with the aim of curing conditions that are currently incurable.
• The Westmead Institute for Medical Research (WIMR)coreStrategic or Co-development PartnerWIMR is a leading Australian medical research institute pioneering breakthroughs in prevention, treatment and cure of serious health issues. Medical research at WIMR is recognised as innovative, progressive and impactful with global reach.
• NSW Health PathologycoreStrategic or Co-development PartnerAustralia's largest public pathology service. At Westmead, NSW Health Pathology is home to the Institute of Clinical Pathology and Medical Research (ICPMR) where scientists conduct world-leading research into infectious diseases, thrombosis and immunology. Provides link between clinical diagnosis and groundbreaking research.
• Health Infrastructure (HI)coreStrategic or Co-development PartnerNSW Government entity responsible for planning and delivering health infrastructure projects across the precinct including the $1 billion+ redevelopment of Westmead Health Precinct.
• Office of Health and Medical Research (OHMR)coreStrategic or Co-development PartnerNSW Government office supporting health and medical research sector. Co-presenter of Innovate Western Sydney event and supporter of precinct activities.
• University of SydneycoreStrategic or Co-development PartnerProvides education in dentistry, nursing, medicine, health science and applied sciences. Consistently ranks as one of top universities for medicine and health in Australia. Research centres at Westmead dedicated to partnering with hospitals to solve healthcare challenges. Co-host of Harvard Hackathon and Innovate Western Sydney.
• Viral Vector Manufacturing Facility (VVMF)coreTechnology or IntegrationAustralian Contract Development Manufacturing Organisation (CDMO) providing services in research, design, development, and manufacture of lentiviral and adeno-associated viral vectors for advanced therapeutic applications. Partners with researchers, clinicians, and bio-pharma companies to accelerate cell and gene therapies to patients.
• National Centre for Immunisation Research and Surveillance (NCIRS)supportingStrategic or Co-development PartnerAustralia's leading organisation in immunisation and vaccines providing expert advice for evidence-informed immunisation policy, evaluation of immunisation programs, and monitoring of vaccine-preventable diseases. Has growing global health program for immunisation system strengthening in Asia and Pacific.
• Cicada Innovations - HealthTech Hub at WestmeadsupportingStrategic or Co-development PartnerHealthTech Hub powered by NSW Government, home to early stage health companies, space for collaboration and commercialisation activation, and landing pad for industry seeking solutions to research and business challenges.
• Western Sydney Startup HubsupportingStrategic or Co-development PartnerHome to dynamic community of entrepreneurs and innovators creating highly skilled jobs in Western Sydney. Located in Parramatta, ideal for entrepreneurs looking to grow business and build networks.
• Investment NSWsupportingGTM or Marketing PartnerNSW Government agency that co-presented Innovate Western Sydney showcase event alongside other precinct partners.
• Cicada InnovationssupportingGTM or Marketing PartnerSupported Innovate Western Sydney event as partner alongside Spacecubed, UNSW, Western Sydney University, LaunchPad, City of Parramatta, Cumberland City Council, and Fairfield City Council.
• SpacecubedminorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner.
• University of New South Wales (UNSW)minorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner.
• Western Sydney UniversityminorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner.
• City of ParramattaminorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner. Precinct is located adjacent to Parramatta, Sydney's second CBD.
• Cumberland City CouncilminorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner in Western Sydney innovation ecosystem.
• Fairfield City CouncilminorGTM or Marketing PartnerSupported Innovate Western Sydney showcase event as partner in Western Sydney innovation ecosystem.

Scale indicators12 records

Recent moves13 records

Expansion highlights5 records

Direct peers

• Melbourne Biomedical Precinct (Parkville): Australia's other major health, research and education precinct anchored by the Royal Melbourne Hospital, Peter MacCallum, the Doherty Institute, University of Melbourne and multiple research institutes. Direct peer in scope (multi-hospital + research + university) and competing for national grants, talent, and industry partnerships.
• Singapore Health District / Biopolis: Government-coordinated health and biomedical precinct integrating public hospitals (e.g., SGH, NUHS), A*STAR research institutes, and Biopolis biotech cluster. Direct peer for a publicly orchestrated hub combining advanced therapeutics, clinical trials, and translational research.
• Boston Longwood Medical Area: Dense medical and academic district anchored by Harvard Medical School, Brigham and Women's, Beth Israel Deaconess, Dana-Farber and Boston Children's. Direct peer in density of academic medical centres, research output, and clinical trial throughput.
• South Australian Health and Biomedical Precinct (Adelaide): Australian health and biomedical precinct co-locating the new Women's and Children's Hospital, Royal Adelaide Hospital, SAHMRI, University of Adelaide and University of South Australia. Direct peer competing for NHMRC funding, biotech industry partnerships, and translational research talent.
• QEII Medical Centre (Perth): Perth-based precinct integrating Sir Charles Gairdner Hospital, Harry Perkins Institute of Medical Research, and the University of Western Australia. Direct peer as another Australian multi-institutional health and research precinct.

Broad incumbents

• Texas Medical Center: World's largest medical complex, comprising more than 60 member institutions including hospitals, research institutes and universities. Comparable as a multi-institutional health precinct with significant clinical trial volume, research output, and global patient referrals.
• Mayo Clinic: Leading integrated academic medical center combining tertiary hospital care, large-scale clinical research, and medical education. Comparable in translational research scale, complex case mix, and reputation for specialty care (relevant given Westmead's gene/phage therapy specialty positioning).
• Cleveland Clinic: Integrated academic health system known for specialty hospital care, Lerner Research Institute, and Lerner College of Medicine. Comparable as a single-entity operator combining specialty clinical services with in-house research and education at scale.
• Karolinska University Hospital / Karolinska Institutet: Swedish academic medical center combining a major tertiary hospital and a top-ranked medical university for translational research. Comparable as a public-sector integrated hub with strong research output and clinical trial capacity.

Others

• Children's Medical Research Institute (CMRI): Listed here as an 'others' connection: CMRI is actually a core partner within the precinct (genetics, cancer, paediatric research). Included to reflect internal ecosystem overlap and to surface it as a focused, peer-comparable paediatric medical research institute.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100092321625376
• LinkedInlinkedin.com/company/westmead-health-precinct
• Instagraminstagram.com/westmeadhealthprecinct

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Westmead Health Precinct